VISIOMED GROUP EO 001
Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. The company was formerly known as Visiom… Read more
VISIOMED GROUP EO 001 (7V91) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, VISIOMED GROUP EO 001 (7V91) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
VISIOMED GROUP EO 001 - Net Assets Trend (None–None)
This chart illustrates how VISIOMED GROUP EO 001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for VISIOMED GROUP EO 001 (None–None)
The table below shows the annual net assets of VISIOMED GROUP EO 001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to VISIOMED GROUP EO 001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
VISIOMED GROUP EO 001 Competitors by Market Cap
The table below lists competitors of VISIOMED GROUP EO 001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EnviroGold Global Limited
OTCQB:ESGLF
|
$31.65 Million |
|
Sea Oil Public Company Limited
BK:SEAOIL
|
$31.65 Million |
|
Loulis Mills S.A.
AT:KYLO
|
$31.66 Million |
|
Nickel 28 Capital Corp
PINK:CONXF
|
$31.66 Million |
|
Affluent Medical SAS
PA:AFME
|
$31.64 Million |
|
9M00
F:9M00
|
$31.64 Million |
|
AfriTin Mining Limited
PINK:AFTTF
|
$31.63 Million |
|
Precipio Inc
NASDAQ:PRPO
|
$31.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in VISIOMED GROUP EO 001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares VISIOMED GROUP EO 001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently VISIOMED GROUP EO 001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares VISIOMED GROUP EO 001's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| VISIOMED GROUP EO 001 (7V91) | €- | N/A | N/A | $31.65 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |